高等学校化学学报

• 研究论文 • 上一篇    下一篇

联吖叮氮氧自由基体系及其衍生物NLO性质的密度泛函理论研究

仇永清, 杜艳青, 刘晓东, 苏忠民, 王荣顺, 赵成大   

  1. 东北师范大学化学学院, 功能材料化学研究所, 长春 130024
  • 收稿日期:2008-09-10 修回日期:1900-01-01 出版日期:2008-12-10 发布日期:2008-12-10
  • 通讯作者: 苏忠民, 王荣顺

DFT Studies on NLO Properties of Di-acridine Nitrogen-oxide Radical and Its Derivatives

QIU Yong-Qing, DU Yan-Qing, LIU Xiao-Dong, SU Zhong-Min*, WANG Rong-Shun*, ZHAO Cheng-Da   

  1. Institute of Functional Material Chemistry, Faculty of Chemistry, Northeast Normal University, Changchun 130024, China
  • Received:2008-09-10 Revised:1900-01-01 Online:2008-12-10 Published:2008-12-10
  • Contact: SU Zhong-Min, WANG Rong-Shun

摘要: 以实验合成的联吖叮氮氧自由基分子为母体, 设计了7个自由基分子. 采用密度泛函理论(DFT) UB3LYP/6-31g(d,p)方法对这些自由基分子不同自旋态的稳定性和非线性光学(NLO)系数进行计算. 结果表明, 联吖叮氮氧自由基分子及其衍生物三重态为稳定基态, 符合自旋极化规则. 引入给吸电子取代基使自由基体系的极化率αs与二阶超极化率γs值有所增大, 且基团的给吸电子能力越强, αs和γs值增加越明显; 对于一阶超极化率βtot, 自由基体系处于单重态时, 取代基的影响较大. 所有自由基分子三重态的NLO系数都小于单重态, 表明可以通过控制体系的自旋多重度来调节体系的NLO性质.

关键词: 联吖叮氮氧自由基, 非线性光学(NLO)系数, UB3LYP方法

Abstract: Seven radicals were designed according to di-acridine nitrogen-oxide radical which had been synthesized. Density functional theory(DFT) UB3LYP/6-31g(d,p) method was employed to calculate the stabi-lities and nonlinear optical(NLO) responses of these radicals in different spin states. The results show that the ground state of di-acridine nitrogen-oxide radicals and derivatives are stable in triplet state according with spin coupling rules. The polarizability αs and the second hyperpolarizability γs of radicals increase with donor and acceptor’s affiliation. Moreover, αs and γs increase obviously with increasing the ability to push/pull an electron. For first hyperpolarizability βtot, substituents have important influence on βtot in singlet state. The singlet radicals have the bigger NLO coefficients than the triplet radicals. Therefore, NLO property of system can be regulated by controlling spin multiplicity of system.

Key words: Di-acridine nitrogen-oxide radical, Nonlinear optical(NLO) coefficient, UB3LYP method

中图分类号: 

TrendMD: